These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 3262940)
61. Suppressive effect of tetrahydrocannabinol on specific T cell subpopulations in the thymus. Pross S; Nakano Y; Smith J; Widen R; Rodriguez A; Newton C; Friedman H Thymus; 1992 Mar; 19(2):97-104. PubMed ID: 1313999 [TBL] [Abstract][Full Text] [Related]
63. The role of zinc in pre- and postnatal mammalian thymic immunohistogenesis. Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 1998; 12(6):695-722. PubMed ID: 9891234 [TBL] [Abstract][Full Text] [Related]
64. Cells reacting with the monoclonal anti-IL-2 receptor antibody AMT-13 in the regenerating thymus of irradiated mice. Takacs L; Osawa H; Liszka K; Diamantstein T Clin Exp Immunol; 1986 May; 64(2):342-7. PubMed ID: 3091302 [TBL] [Abstract][Full Text] [Related]
65. A new lymphocyte surface antigen defined by a monoclonal antibody (9F3) to the T cell population expanding in MRL/Mp-lpr/lpr mice. Dumont FJ; Habbersett RC; Nichols EA J Immunol; 1984 Aug; 133(2):809-15. PubMed ID: 6234361 [TBL] [Abstract][Full Text] [Related]
66. Development and ontogeny of hamster T cell subpopulations. Witte PL; Streilein JW J Immunol; 1986 Jul; 137(1):45-54. PubMed ID: 3486916 [TBL] [Abstract][Full Text] [Related]
67. Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin. Reimann J; Bellan A; Kabelitz D J Immunol; 1987 Feb; 138(4):1042-50. PubMed ID: 3492539 [TBL] [Abstract][Full Text] [Related]
68. Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens. Takesue BY; Bartik MM; Mokyr MB Int J Immunopharmacol; 1987; 9(6):705-17. PubMed ID: 2891627 [TBL] [Abstract][Full Text] [Related]
69. Differential effects of X-irradiation and cyclosporin-A administration on the thymus with respect to the generation of cyclosporin-A-induced autoimmunity. Beijleveld LJ; Damoiseaux JG; Van Breda Vriesman PJ Dev Immunol; 1995; 4(2):127-38. PubMed ID: 9700362 [TBL] [Abstract][Full Text] [Related]
70. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128 [TBL] [Abstract][Full Text] [Related]
71. Tissue localization and biochemical characteristics of a new thymic antigen recognized by a monoclonal thymocytotoxic autoantibody from New Zealand black mice. Bray KR; Gershwin ME; Ahmed A; Castles JJ J Immunol; 1985 Jun; 134(6):4001-8. PubMed ID: 3921616 [TBL] [Abstract][Full Text] [Related]
72. Fluorescence analysis and anatomic distribution of mouse T lymphocyte subsets defined by monoclonal antibodies to the antigens Thy-1, Lyt-1, Lyt-2, and T-200. van Ewijk W; van Soest PL; van den Engh GJ J Immunol; 1981 Dec; 127(6):2594-604. PubMed ID: 6975331 [No Abstract] [Full Text] [Related]
73. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells. Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595 [TBL] [Abstract][Full Text] [Related]
74. Activation requirements for normal T cells: accessory cell-dependent and -independent stimulation by anti-receptor antibodies. Bekoff M; Kubo R; Grey HM J Immunol; 1986 Sep; 137(5):1411-9. PubMed ID: 3489033 [TBL] [Abstract][Full Text] [Related]
75. Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity. Pope M; Kotlarski I Immunology; 1994 Feb; 81(2):183-91. PubMed ID: 7512525 [TBL] [Abstract][Full Text] [Related]
76. Growth and differentiation in vitro of the accumulating Lyt-2-/L3T4- subset in lpr mice. Budd RC; MacDonald HR; Lowenthal JW; Davignon JL; Izui S; Cerottini JC J Immunol; 1985 Dec; 135(6):3704-11. PubMed ID: 3934265 [TBL] [Abstract][Full Text] [Related]
77. Differentiation of T cells into helper cells from immature precursors: identification of a target cell for a proline-rich polypeptide (PRP). Wieczorek Z; Zimecki M; Spiegel K; Lisowski J; Janusz M Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):313-22. PubMed ID: 2534785 [TBL] [Abstract][Full Text] [Related]
78. Development of TCR-gamma delta CD4-CD8+ alpha alpha but not TCR-alpha beta CD4-CD8+ alpha alpha i-IEL is resistant to cyclosporin A. Lin T; Matsuzaki G; Umesue M; Omoto K; Yoshida H; Harada M; Singaram C; Hiromatsu K; Nomoto K J Immunol; 1995 Nov; 155(9):4224-30. PubMed ID: 7594578 [TBL] [Abstract][Full Text] [Related]
79. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo. Sprent J; Schaefer M; Lo D; Korngold R Immunol Rev; 1986 Jun; 91():195-218. PubMed ID: 2942460 [TBL] [Abstract][Full Text] [Related]
80. Age influence on the thymic capacity to promote differentiation of T cells: induction of different composition of T cell subsets by aging thymus. Utsuyama M; Kasai M; Kurashima C; Hirokawa K Mech Ageing Dev; 1991 May; 58(2-3):267-77. PubMed ID: 1875734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]